Published in CNS Spectr on February 01, 2009
Antipsychotic agents: efficacy and safety in schizophrenia. Drug Healthc Patient Saf (2012) 0.79
Effect of psychotropic drug treatment on sterol metabolism. Schizophr Res (2017) 0.78
Use of Aripiprazole Long Acting Injection in Negative Symptoms of Schizophrenia. Case Rep Psychiatry (2016) 0.75
Mental disorders in megacities: findings from the São Paulo megacity mental health survey, Brazil. PLoS One (2012) 1.56
Comparison of repetitive transcranial magnetic stimulation and electroconvulsive therapy in unipolar non-psychotic refractory depression: a randomized, single-blind study. Int J Neuropsychopharmacol (2006) 1.20
Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment. World J Biol Psychiatry (2010) 1.12
Increased serum IL-1beta level in Alzheimer's disease and mild cognitive impairment. Dement Geriatr Cogn Disord (2009) 1.10
Lithium reduces Gsk3b mRNA levels: implications for Alzheimer Disease. Eur Arch Psychiatry Clin Neurosci (2008) 1.03
The detection of depression in medical setting: a study with PRIME-MD. J Affect Disord (2006) 1.00
The use of ASB-14 in combination with CHAPS is the best for solubilization of human brain proteins for two-dimensional gel electrophoresis. Brief Funct Genomic Proteomic (2007) 0.97
Profiles of functional deficits in mild cognitive impairment and dementia: benefits from objective measurement. J Int Neuropsychol Soc (2010) 0.96
Recognition of depressive symptoms by physicians. Clinics (Sao Paulo) (2009) 0.93
Evaluation of the factors interfering with drug treatment compliance among Brazilian patients with schizophrenia. Rev Bras Psiquiatr (2005) 0.91
Serum brain-derived neurotrophic factor level is reduced in antidepressant-free patients with late-life depression. World J Biol Psychiatry (2010) 0.91
Lithium as a treatment of clozapine-induced neutropenia: a case report. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.91
Increased soluble TNF receptor 2 in antidepressant-free patients with late-life depression. J Psychiatr Res (2010) 0.91
Use of psychoactive substances and sexual risk behavior in adolescents. Subst Use Misuse (2002) 0.88
Clinical aspects of super-refractory schizophrenia: a 6-month cohort observational study. Rev Bras Psiquiatr (2007) 0.88
Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer's disease. J Alzheimers Dis (2010) 0.88
Understanding tDCS effects in schizophrenia: a systematic review of clinical data and an integrated computation modeling analysis. Expert Rev Med Devices (2014) 0.87
The more information, the more negative stigma towards schizophrenia: Brazilian general population and psychiatrists compared. Psychiatry Res (2012) 0.86
Interleukin-1beta serum levels is increased in antidepressant-free elderly depressed patients. Am J Geriatr Psychiatry (2010) 0.85
Diagnostic transitions in mild cognitive impairment subtypes. Int Psychogeriatr (2009) 0.85
31P-spectroscopy of frontal lobe in schizophrenia: alterations in phospholipid and high-energy phosphate metabolism. Schizophr Res (2002) 0.84
Conjugated estrogens as adjuvant therapy in the treatment of acute schizophrenia: a double-blind study. Schizophr Res (2004) 0.84
To treat or not to treat? A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci (2009) 0.83
Vocational rehabilitation improves cognition and negative symptoms in schizophrenia. Schizophr Res (2010) 0.83
Lower phosphorylated glycogen synthase kinase-3B levels in platelets of patients with schizophrenia: increment by olanzapine treatment. Eur Arch Psychiatry Clin Neurosci (2014) 0.82
Safety and tolerability of antipsychotics: focus on amisulpride. Drug Healthc Patient Saf (2010) 0.81
Language impairment in euthymic, elderly patients with bipolar disorder but no dementia. Int Psychogeriatr (2008) 0.81
Platelet GSK3B activity in patients with late-life depression: marker of depressive episode severity and cognitive impairment? World J Biol Psychiatry (2011) 0.81
Stigma toward schizophrenia: do all psychiatrists behave the same? Latent profile analysis of a national sample of psychiatrists in Brazil. BMC Psychiatry (2013) 0.81
A 6-month randomized controlled trial to test the efficacy of a lifestyle intervention for weight gain management in schizophrenia. BMC Psychiatry (2013) 0.80
Switching from oral risperidone to flexibly dosed oral paliperidone extended-release: core symptoms, satisfaction, and quality of life in patients with stable but symptomatic schizophrenia: the RISPALI study. Curr Med Res Opin (2013) 0.80
A multicenter, open-label trial to evaluate the quality of life in adults with ADHD treated with long-acting methylphenidate (OROS MPH): Concerta Quality of Life (CONQoL) study. J Atten Disord (2012) 0.80
SHORT COMMUNICATION: Apolipoprotein E genotype and cognition in bipolar disorder. CNS Neurosci Ther (2010) 0.80
COMT Met (158) modulates facial emotion recognition in bipolar I disorder mood episodes. J Affect Disord (2012) 0.79
Antipsychotic agents: efficacy and safety in schizophrenia. Drug Healthc Patient Saf (2012) 0.79
An open trial of reboxetine in HIV-seropositive outpatients with major depressive disorder. J Clin Psychiatry (2003) 0.79
Relative bioavailability of two oral formulations of risperidone 2 mg: A single-dose, randomized-sequence, open-label, two-period crossover comparison in healthy Brazilian volunteers. Clin Ther (2010) 0.79
Long-term decrease in immediate early gene expression after electroconvulsive seizures. J Neural Transm (Vienna) (2012) 0.78
Allelic association analysis of phospholipase A2 genes with schizophrenia. Psychiatr Genet (2004) 0.78
The impact of psychiatric comorbidity on length of stay of medical inpatients. Gen Hosp Psychiatry (2003) 0.78
Structural brain abnormalities in early-onset schizophrenia. Arq Neuropsiquiatr (2006) 0.77
Cognitive training for schizophrenia in developing countries: a pilot trial in Brazil. Schizophr Res Treatment (2013) 0.77
Cognitive-linguistic deficits in euthymic elderly patients with bipolar disorder. J Affect Disord (2013) 0.77
Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer's Disease. Neuromolecular Med (2015) 0.77
Contribution of transcranial direct current stimulation on inhibitory control to assess the neurobiological aspects of attention deficit hyperactivity disorder: randomized controlled trial. JMIR Res Protoc (2015) 0.76
The psychopathological factors of refractory schizophrenia. Rev Bras Psiquiatr (2005) 0.76
Investigation of possible association between Ser9Gly polymorphism of the D3 dopaminergic receptor gene and response to typical antipsychotics in patients with schizophrenia. Sao Paulo Med J (2006) 0.76
Antipsychotic drugs decrease iPLA2 gene expression in schizophrenia. Schizophr Res (2013) 0.76
Sertindole in the management of schizophrenia. J Cent Nerv Syst Dis (2011) 0.75
Correction: The Absence of CYP3A5*3 Is a Protective Factor to Anticonvulsants Hypersensitivity Reactions: A Case-Control Study in Brazilian Subjects. PLoS One (2015) 0.75
Formal Thought Disorder and language impairment in schizophrenia. Arq Neuropsiquiatr (2012) 0.75
Refractory psychotic symptoms in a patient with homozygous sickle cell disease: a 24-month follow-up. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.75
Mental healthcare in South America with a focus on Brazil: past, present, and future. Curr Opin Psychiatry (2016) 0.75
[Biologic artifacts in quantitative EEG]. Arq Neuropsiquiatr (2006) 0.75
Protein Expression of BACE1 is Downregulated by Donepezil in Alzheimer's Disease Platelets. J Alzheimers Dis (2016) 0.75
Glycogen Synthase Kinase-3β: Variation over Time and the Possible Association with Mood and Cognition in Healthy Individuals. Neuropsychobiology (2016) 0.75